Abstract One of the main limitations for heterologous protein production in the yeast Saccharomyces cerevisiae is the protein-folding capacity in the endoplasmic reticulum (ER). Accumulation of unfolded proteins triggers the unfolded protein response (UPR), which resolves the stress by increasing the capacity for protein folding and removal of unfolded proteins by the ER-associated degradation (ERAD) system. In order to analyze the influence of ERAD on production of a human IgG, we disrupted ERAD at different stages by deletion of the HTM1, YOS9, HRD1, HRD3, or UBC7 gene, with or without a disruption of the UPR by deletion of the IRE1 gene. All deletion strains were viable and did not exhibit a growth phenotype under normal growth conditions. Deletion of HTM1 resulted in a small increase in antibody production, whereas a small decrease in antibody production was observed in the Δhrd1, Δhrd3, and Δubc7 yeast strains, and a stronger decrease in the Δyos9 yeast strain. Deletion of the IRE1 gene had contrasting effects in the ERAD mutants, with a strongly decreased production in wild-type cells and partially reversed effects in combination with the Δhtm1 or the Δyos9 deletions. In order to study IgG clearance from the ER, an assay was developed using the inhibitory effect of glucose on the GAL1 promoter that is driving IgG expression. The Δyos9Δire1and Δhtm1Δire1 strains showed a delayed IgG clearance from the cells, showing that removal of components for the generation and recognition of the glycan signal needed for ERAD-mediated protein degradation might increase the IgG ER residence time.
Introduction
The yeast Saccharomyces cerevisiae has been widely used as an expression host for the production of heterologous proteins. The advantages of this host as an expression system include a long history of scientific research leading to a vast amount of data from single component to cellular level. With the advent of glycoengineered yeasts, the production of therapeutic glycoproteins with yeast is now tangible (Li et al. 2006; Parsaie Nasab et al. 2013; Piirainen et al. 2014 ). However, it is known that bottlenecks in the secretion pathway lead to suboptimal and variable production levels.
Although possessing a eukaryotic protein folding and quality control system, expression of heterologous glycoproteins such as full-length antibodies remains a challenge and production titers remain low. It has been shown that by optimizing the production process, yields can be increased, however, without increasing the specific productivity of the cells (Gasser and Mattanovich 2007; Potgieter et al. 2009 Potgieter et al. , 2010 . Therefore, the cellular limitations still remain. One particular bottleneck might be found in the endoplasmic reticulum (ER), and it has been reported that residence times of heterologously expressed mammalian proteins in the yeast ER are up to 5 h (Wittrup et al. 1994) , putatively leading to the elimination of parts of the slow folding proteins.
Cell engineering approaches to increase specific productivity have proven to be complicated. Although many hurdles have been overcome by overexpression of molecular chaperones and other folding factors, of transport factors to enhance vesicular transport, or by deletions of sorting receptors to prevent miss-sorting and of proteins involved in proteolytic degradation, it has been shown that these results tend to be host and protein specific (Delic et al. 2014 ). In addition, often, multiple steps are limiting protein production, therefore complicating the cell engineering process. However, systems biology might give more insight in the role of individual processes in the complex protein synthesis network and thus aid in finding the right approach for cell engineering (Hou et al. 2012) .
One critical factor in protein folding is the maintenance of protein homeostasis in the ER. ER homeostasis can be perturbed when the folding capacity of the ER is saturated by expression of high amounts of heterologous proteins leading to upregulation of the yeast ER quality control (QC) machinery by the unfolded protein response (UPR). Aiming to enhance correct protein folding and to dispose of incorrectly folded proteins, the QC system includes amongst others folding enzymes, chaperones, and the ERassociated protein degradation (ERAD) system. Although constitutively active, the QC machinery is vastly upregulated by the UPR (Friedlander et al. 2000) . Key components of this ER process are shown in Fig. 1 . Nascent proteins are imported into the ER and need to reach their native state before they can be exported. In the case of glycoproteins, the folding state is mainly monitored via their glycoforms, and the N-glycans control the fate of the proteins (Helenius and Aebi 2004) . The nascent glycoprotein is initially N-glycosylated with a Glc 3 Man 9 GlcNAc 2 glycan, and during the folding process, the three glucoses are trimmed off. Mns1p, a slowly acting mannosidase, removes the terminal mannose from the B-branch of the glycan tree, to signal removal of the protein from further folding cycles (Herscovics 2001) . The resulting Man 8 GlcNAc 2 glycan, when present on a still unfolded protein, is recognized by the Pdi1p/Htm1p complex (Gauss et al. 2011) . The Htm1p mannosidase of this complex further trims down the glycan to the Man 7 GlcNAc 2 form by removing the terminal mannose at the C-branch of the glycan, in order to create the substrate for HRD ligase-mediated glycoprotein degradation (Clerc et al. 2009 ). The lectin Yos9p is part of this HRD ligase complex and recognizes glycans containing the now available terminal α1,6 linked mannose residues (Quan et al. 2008) . Next, the protein is targeted toward the HRD ligase complex for retrotranslocation, ubiquitination, and finally Fig. 1 Overview of key players in UPR and ERAD. Nascent proteins are imported into the ER, where glycoproteins are glycosylated by the oligosaccharyltransferase. The folding process is monitored through their glycoforms, and when successfully folded, proteins are exported from the ER. However, glycans from misfolded proteins are trimmed down and recognized by components of the ERAD system, which targets them for retrotranslocation into the cytosol and subsequent degradation by the proteasome. Additionally, unfolded proteins can activate the UPR, which leads to upregulated transcription of various genes, including genes encoding various ERAD components and ER chaperones proteasomal degradation (Benitez et al. 2011) . The HRD ligase core-complex consists of the proteins Hrd1p, Hrd3p, Usa1p, and Der1p. The Hrd3 protein works concertedly with Yos9p for targeting of the unfolded protein to the complex. After this, the ERAD substrate is retrotranslocated across the ER membrane and ubiquitinated by Hrd1p together with the ubiquitin conjugating enzyme Ubc7p, which is located on the cytoplasmic site of the ER membrane (Hiller et al. 1996) . The substrate is finally degraded by the proteasome, which is recruited by Hrd1p (Nakatsukasa et al. 2013) .
In the present study, we studied the effects of the cellular glycoprotein QC system components on expression of a fulllength antibody in S. cerevisiae. We analyzed the effect of deleting various components of ERAD, alone or in combination with an inactivated UPR, on cellular growth, protein secretion, and IgG clearance.
Materials and methods

Generation of strains and plasmids
All S. cerevisiae strains used in this study were derived from the parental strain SS328 (ATCC® MYA193™) and are listed in Table 1 . Gene deletion strains were constructed using the method from Hegemann and Heick (2011) . The target gene loci were deleted by replacement with a PCR product containing the KanMX4 or the NatMX cassette and flanking target sequences. Plasmids pRS305K (Taxis and Knop 2006) and pUG74 (Hegemann and Heick 2011) were used as template for PCR amplification of the kanamycin (KanMX4) or the nourseothricin resistance marker cassettes (NatMX), respectively. The lithium acetate method was used for transformation of yeast cells. After transformation, cells were grown on medium supplemented with 200 μg/mL G418 (Sigma-Aldrich, Helsinki, Finland), 200 μg/ mL LEXSY NTC (Jena Bioscience, Jena, Germany), or a combination of both antibiotics for selection of a second deletion.
The light and heavy chains of the human monoclonal anti-CD20 IgG (Li et al. 2006) were genetically fused to the secretion signal comprising amino acids 1-17 of the endogenous yeast acid phosphatase (PHO5 gene). Heavy and light chains of the IgG were amplified from plasmid pAX88 using PCR and oligonucleotide pairs OAF015 (5′-AAACTAGTATGTTTAAATCT GTTGTTTATTCAATTTTAGCCGCTTCTTTGGCCAATGC ACAGGTACAACTGCAGC) and OAF016 (5′-AACTCGAG TCATTTACCCGGAGACAGGG), and OAF017 (5′-AATC TAGAATGTTTAAATCTGTTGTTTATTCAATTTTAGCCG CTTCTTTGGCCAATGCACAAATTGTTCTCTCCCAGTC) and OAF018 (5′-AACTCGAGCTAACACTCTCCCCTGTT G) for heavy and light chain, respectively. The forward primers contained the signal sequence. The PCR-amplified fragments were inserted into XbaI XhoI or SpeI XhoI sites of the CEN/ ARS plasmid pRS416-Gal (Mumberg et al. 1995) , creating pEK1 and pEK3, respectively. The pEK1 NaeI-NdeI fragment, encompassing vector backbone, promoter, light-chain complementary DNA (cDNA), and terminator, was ligated with pEK3 Ecl136II-NdeI fragment, encompassing the heavy chain cDNA with promoter and terminator, creating pEK5. All strains were transformed with the antibody expression vector.
Cultivation and growth assays
Strains were grown in YPD (1 % yeast extract, 2 % peptone, and 2 % glucose), in minimal medium (0.67 % yeast nitrogen base without amino acids (YNB) and 2 % glucose or raffinose, with supplementation of 20 mg/L of adenine, 20 mg/L of histidine, and 30 mg/L of lysine) or in synthetic drop out (SD) medium lacking uracil for plasmid selection. All media components and reagents were obtained from Sigma-Aldrich (Helsinki, Finland), unless stated otherwise. YNB was obtained from BD (Vantaa, Finland) . Spotting assays were performed on YPD, SD, and SGal (supplemented with 2 % galactose) agar plates (2 %w/v). Exponentially growing cultures were harvested, washed with water, diluted to an OD 600 of 0.4, and serially diluted into ddH 2 O. Five microliters of each serial dilution was spotted. The plates were incubated for 48 and 72 h at 25, 30, and 37°C, after which pictures were taken.
For recording of growth curves, cultures of exponentially growing cells were diluted to OD 600 of 0.1 in YPD. Two hundred microliters of these cultures were grown in a microtiter plate, with continuous shaking at 30°C using a Bioscreen C MBR system (Oy Growth Curve Ab Ltd, Finland). OD 600 measurements were taken every 30 min for 24 h. Statistical analysis of μ max values was done using single factor ANOVA.
Precultures for IgG expression experiments were grown in 5 mL of minimal medium for 16 h at 30°C, 220 rpm, and used to inoculate 1 mL of fresh media to a starting OD 600 of 0.1 in 96-deepwell plates. Cells were grown for 6 h at 30°C, 280 rpm, after which protein expression was induced with addition of 4 % galactose at 25°C. After 24 h of production, OD 600 values were measured in 96-well plates using a BioTek Eon spectrophotometer (BioTek, Winooski, USA). For ELISA analysis, the cultures were clarified by centrifugation for 5 min at relative centrifugal force (rcf) of 3214. The clarified culture supernatants were adjusted to 1× PBT (PBS (135 mM NaCl, 2.5 mM KCl, 10 mM Na 2 HPO 4 , 1.75 mM KH 2 PO 4 ) + 0.05 % Tween-20) and stored at −20°C until analysis.
Antibody titer determination
An enzyme-linked immunoassay (ELISA) was used to determine antibody titers. The ELISA assay was automated on a HAMILTON Star line liquid handling station (Hamilton, Bonaduz, Switzerland). All antibodies were obtained from Sigma-Aldrich (Helsinki, Finland); human IgG standard antibody was obtained from Calbiochem (Merck Millipore, Billerica, USA). Ninety-six-well plates were coated with 100 μL/ well of 4.2 μg/mL of goat anti-human IgG (Fc specific) antibody in PBS shaking overnight at 4°C. Plates were washed four times with 200 μL PBT and blocked for 45 min in PBT at 22°C with occasional shaking. Serial dilutions of standard antibody were performed in PBT. Two hundred microliters of samples in triplicates or standard antibody in duplicates were added to the wells, and the plates were incubated for 90 min while shaking at room temperature. After incubation, wells were washed three times with 200 μL of PBT. One hundred microliters/well of 1:4000 dilution of goat anti-human IgG (Fc specific) peroxidase-labeled antibody was added and allowed to bind for 1 h at room temperature while shaking. After incubation, wells were washed three times with 200 μL of PBT. For detection, 80 μL/well substrate solution (0.2 mg/mL ophenylenediamine, 3 μL of 30 % H 2 O 2 per 10-mL solution in 0.05 M phosphate citrate buffer) was added. After 8 min, the reaction was quenched by addition of 80 μL/well of 3 M H 2 SO 4 . Absorbance was read at 405 nm using a BioTek Synergy 2 spectrophotometer. Data evaluation was done with Gen5 software (BioTek, Winooski, USA).
ER clearance assay
Precultures were grown in 5 mL of minimal medium at 30°C, 220 rpm for 15 h. Exponentially growing cells were induced with 2 % galactose when they reached an OD 600 of 0.8 and transferred to 25°C. After 4 h of expression, either 200 μg/mL of cycloheximide, 2 % glucose, or 200 μg/mL of cycloheximide + 2 % glucose was added to repress the IgG production or the same volume of water for control samples. The cells were collected 0, 2, 4, and 6 h after addition of inhibitors or water.
Ten OD 600 units of cells were collected by centrifugation, and the cell pellets were resuspended in 500 μL of lysis buffer (100 mM Tris HCl buffer, pH 7.4 containing 1× complete®, EDTA-free protease inhibitor cocktail (Roche, Basel, Switzerland) and 1 mM phenylmethylsulfonyl fluoride (PMSF)). The same volume of acid washed glass beads was added, and samples were vortexed for 10 min at 4°C using a Disruptor genie (Scientific Industries, Bohemia, USA). After settling of the beads, the supernatant was transferred to a new tube. The glass beads were washed with 500 μL of lysis buffer by vortexing the tubes twice for 30 s, while keeping them for 30 s on ice in between. The combined supernatants were pelleted, and the pellets were resuspended in 100 μL of sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (62.5 mM Tris-HCl (pH 6.8), 2 % SDS, 10 % glycerol, 5 % β-mercaptoethanol, and 0.005 % bromophenol blue). Samples were heated for 5 min at 65°C, after which they were centrifuged for 5 min at 14, 000 rcf and the supernatants were used for analysis.
Ten microliters of sample was loaded onto a 12.5 % SDSpolyacrylamide gel, and the electrophoresis was run in SDStris-glycine buffer. For each sample, replicate gels and blots for detection of IgG and tubulin were prepared. After the SDS-PAGE proteins were transferred to a nitrocellulose membrane using western blotting, a 1:10,000 dilution of anti-human IgG (Fc specific) peroxidase-labeled antibody produced in goat was used for staining. A 1:10,000 dilution of anti-tubulin [EPR13799] produced in rabbit (Abcam, Cambridge, UK) in combination with a 1:10,000 dilution of goat anti-rabbit IgG (Fc specific) peroxidase-labeled was used. Signal detection was done with the ECL western Blotting Detection kit (GE Healthcare, Helsinki, Finland) following the manufacturer's instructions. Analysis and quantification of band intensities were performed using the Bio-Rad Image Lab Software (Bio-Rad, Hercules, USA). Anti-tubulin blots were used as loading controls.
Results
The influence of deletions on growth rates
The ERAD pathway participates in ER protein homeostasis by targeting and removing misfolded proteins from the ER and channeling them toward the ubiquitin-proteasomal degradation machinery. We have selected five genes from different stages of the ERAD pathway to analyze the effects of ERAD disruptions on production of a model antibody. The genes HRD1, HRD3, UBC7, HTM1, and YOS9 were deleted in the wild-type S. cerevisiae strain SS328. Additionally, IRE1 was deleted in all five deletion strains and SS328 to prevent induction of UPR and mitigation of putative ERAD phenotypes. Finally, the ALG3 gene was deleted in the SS328 and Δire1 strains to create a glycoform that bona fide escapes the quality control system. First, in order to study the effect of these different mutations on yeast, growth curves were recorded. In short, exponentially growing cultures were diluted in YPD to OD 600 of 0.1 and 200 μL of the diluted culture were added to the wells of microtiter plates. The cultures were grown for 24 h at 30°C with constant shaking, and OD 600 measurements were automatically recorded every 30 min. The resulting growth curves are shown in Fig. 2 . All strains displayed a similar growth behavior, reaching the stationary phase after 10 h of cultivation. The μ max was reached for all strains after 2.5 to 4 h of cultivation ( Table 2 ). The μ max values of the different strains ranged from 0.505±0.007 to 0.581±0.015 in the wild-type strain background and 0.497±0.012 to 0.562±0.019 in the Δire1 genetic background. However, statistical analysis of μ max values using single factor ANOVA did not find any significant differences between the means of the different strains (P>0.05).
Effects of deletions of QC and ERAD components on antibody production and intracellular accumulation
To examine the effects of deletions in the ERAD and UPR pathways on heterologous protein production, all deletion and wild-type strains were transformed with the antibody producing plasmid pEK5. The yeast strains carrying the plasmid were diluted from precultures into 96-deepwell plates. Cultures were grown to exponential growth phase at 30°C, and antibody expression was induced by the addition of 4 % galactose. After 24 h of growth at 25°C, the cultures were harvested, and the OD 600 values and the IgG levels in the culture supernatants were determined. The variation between OD 600 values of the different strains was 13 %. IgG levels were normalized to cell densities of the cultures (Fig. 3) .
Inactivating the ERAD pathway by deleting different genes led to several production phenotypes. Deletion of the genes encoding for three components of the retrotranslocation complex (HRD1, HRD3, and UBC7) gave similar results, and the secreted antibody titers reached 63, 69, and 68 %, Fig. 2 Growth of deletion strains in liquid-rich media. Exponentially growing cells were diluted to OD 600 of 0.1 in YPD and grown in microtiter plates for 24 h at 30°C with continuous shaking, while OD 600 was measured every 30 min. The growth curves represent average OD 600 of four replicates. The average % standard error ranges from 1.60 to 4.15 %. WT wild-type respectively, of the wild-type production level. In contrast, deletion of the HTM1 gene was the only beneficial deletion for protein production yield, with an increase in antibody production of 15 %. However, when disrupting a later step in the ERAD, the recognition of the trimmed N-glycan mediated by Yos9p, production levels dropped to 18 %. In a next set of experiments, we tested these different gene disruptions in a yeast background incapable to mount the UPR. Therefore, each gene disruption was combined with the IRE1 deletion. Blocking the UPR by deletion of the IRE1 gene was detrimental for protein production as IgG levels dropped to 7 % relative to the wild-type levels. Interestingly, combining the IRE1 deletion with deletions in the ERAD pathway partially rescued the production phenotype of the IRE1 deletion strain. In the Δhrd1Δire1, Δhrd3Δire1, and Δubc7Δire1 strains, production levels were comparable to their respective single mutants reaching 74, 62, and 81 % of the wild-type levels. Remarkably, combining Δhtm1 with Δire1 led to an almost two thirds decrease compared to the single Δhtm1 strain. However, production was still almost seven times higher than the Δire1 strain. In contrast, introducing the IRE1 deletion in the Δyos9 deletion strain increased production levels fourfold reaching 76 % of wild-type levels. The Δalg3 deletion strain showed improved production and seemed not to be affected by an abolished UPR, with production levels of 120 and 131 % compared to the wild-type and the Δire1 strain, respectively.
Due to the observed differences in the amount of secreted antibodies in the culture supernatant, we analyzed whether these differences would be reflected in the intracellular concentrations of IgG. Therefore, we determined relative concentrations of the intracellular IgG amounts by measuring signal intensities of IgG on western blots and normalizing them with the signal intensities of tubulin of corresponding cell extracts. The results indicated that 24 h after induction, intracellular IgG levels varied between the different strains. For the strains with deletions of ERAD components, the normalized IgG levels ranged from 1.1 to 1.8 times the amount of IgG compared with wild-type cells. For the strains in the Δire1 background, the normalized IgG levels ranged from 0.8 to 1.6 times the amount of IgG compared with the Δire1 deletion strain or 0.7 to 1.5 times the amount of IgG compared with wild-type cells. No correlation between the total secreted amount of IgG detected in the culture supernatant and the intracellular amounts of IgG was found.
Effects of deletions on growth under IgG production conditions
To analyze if any of the IgG-producing deletion strains displayed a growth phenotype, serial dilutions of exponentially growing cells were spotted on solid media. The plates used were rich media (YPD) and selective media (SD-URA and SGal-URA) and were incubated at 25, 30, and 37°C. Pictures were taken after 48 h (YPD and SD-URA) or 72 h (SGal-URA). All strains grew indistinguishably from each other on rich media (data not shown). In the selective medium set of experiments, the strains harboring the IgG expression plasmids were grown under inducing and non-inducing conditions. The results showed that under inducing conditions, the Δyos9Δire1 and Δhtm1Δire1 strains displayed strongly reduced growth compared to the parental strains. In particular at elevated temperatures of 30 and 37°C, these two strains were not able to grow. In contrast, the Δhrd3Δire1 and Δubc7Δire1 strains displayed improved growth properties under inducing conditions at elevated temperatures (Fig. 4) . The Δalg3 deletion strain in SS328 and in the Δire1 strain background displayed a growth phenotype when grown on the SD-URA and SGal-URA plates at 37°C. This effect is most likely unrelated to ERAD or UPR effects and has been described as being caused by a changed cell wall composition (Bailey and Schulz 2013) .
Deletions of ERAD components and UPR abolishment lead to differences in IgG clearance
In order to follow the fate of the folding IgG in the ER, we developed an assay to study ER depletion. Exponentially growing cultures of wild-type cells were induced with galactose and allowed to express IgG for 4 h. After 4 h, protein production was inhibited by the addition of 2 % glucose, 200 μg/mL cycloheximide, or a combination of both to the Fig. 3 Effects of deletion of ERAD components on antibody production. Strains were grown in 96-well plate format into the exponential phase, and protein production was induced with galactose for 24 h. IgG concentration in medium was quantified using ELISA and normalized to cell concentration using OD 600 measurements. Error bars indicate standard error from nine independent cultures. *P<0.05; **P<0.01; ***P<0.001 (versus wild-type control, by Student's two-tailed t test). The strains used were wild-type (WT) and deletions strains. Deletion of IRE1 is marked with + and −
cultures. An equal amount of ddH 2 O was added to control samples. Zero, 2, 4, and 6 h after inhibition, ten OD 600 units of cells were collected for preparations of cell extracts. The cell extracts were separated using SDS-PAGE and transferred to nitrocellulose membranes. The presence of IgG was visualized using an anti-IgG western blot, and equal loading of the gels was verified using an anti-tubulin western blot; thus, for each sample, two replicates were analyzed. The signal intensities were quantified, and the IgG signal intensity was normalized to the corresponding intensity of the tubulin signal. The IgG clearance was fastest in the cultures where glucose alone or glucose in combination with cycloheximide was added, with an IgG signal half-life of 1.36 and 1.18 h, respectively. Upon cycloheximide treatment of the cells, a delayed cellular IgG clearance with an IgG signal half-life of 1.88 h was observed (Fig. 5a) , indicating that the general inhibition of protein synthesis by cycloheximide negatively influences normal protein processing. Therefore, in contrast to assays relying on the inhibition of protein synthesis using cycloheximide, we decided to take advantage of the repressible effect of glucose on the galactose promoter to switch off expression, without affecting the general protein synthesis and ensuring conservation of normal processing conditions. Next, the experimental setup was extended to include all strains used in the earlier experiments and performed as described above, using 2 % glucose as inhibitor of the IgG production. Equal loading of the blots was confirmed using an anti-tubulin antibody. Selected western blots are shown in Fig. 5b , with a representative anti-tubulin blot as a loading control. As expected, the non-repressed cultures kept producing the IgG protein during the course of the experiment. In samples prepared from the wild-type yeast expressing IgG, the IgG levels decreased fastest, and no IgG was detected anymore after 6 h. In contrast, the IgG levels decreased more slowly in samples prepared from the Δubc7, Plates were incubated at 25, 30, or 37°C for 2 days (SD-URA) or 3 days (SGal-URA) Fig. 5 Analysis of IgG clearance using western blot. Antibody expression was induced in exponentially growing cultures with galactose for 4 h, after which protein expression was inhibited and IgG clearance was for followed for 0, 2, 4, and 6 h. After incubation periods, cell extracts were prepared from the cultures and analyzed using SDS-PAGE and western blot. a Cultures of the wild-type strains expressing IgG were treated with glucose (gluc), cycloheximide (cyc), glucose and cycloheximide or water (control). b Cultures of the wild-type (WT) and all strains containing a deletion were treated with glucose or water, and IgG clearance was monitored over a period of 6 h. A representative blot for tubulin, used as loading control, is shown for both sets of experiments Δhtm1Δire1, and Δyos9Δire1 strains, indicating that the IgG processing was reduced in these strains. In the other strains, the IgG clearance was similar to the clearance observed in the wild-type yeast. In general, a higher variability in IgG clearance was observed in single deletion strains compared to the double deletion strains.
In order to get quantitative data of the IgG clearance, intensities of IgG and tubulin bands were measured using BioRad Image Lab software. Band intensity of time point 0 was set to 100 %, and relative IgG quantities were calculated for the different time points. Quantifications of corresponding anti-tubulin blots were used to correct the anti-IgG intensities for loading differences, and the resulting clearance curves are show in Fig. 6 .
The decrease of the IgG levels in cell extracts was fastest in the wild-type cells, and a highly similar IgG depletion was observed in the Δire1 strain. In general, the strains with deletions in ERAD showed a delayed clearance, but the levels of IgG depletion were comparable to the wild-type strain and the Δire1 strain at the end of the assay. Similar clearance kinetics as in the wild-type cells were observed in the Δhtm1, Δalg3Δire1, Δhrd1Δire1, Δhrd3Δire1, and Δire1 strains. For these strains, only 15 to 25 % of the IgG were left after 2 h, after 4 h, this was further decreased to approximately 5 %, and at the latest time point on average, less than 2 % of the original IgG amount was observed in these strains. For the rest of the strains with only deletions in ERAD components, the Δhrd1 and Δubc7 strains showed a delayed clearance. In the Δhrd1 strain, the normalized IgG amount after 2 h was similar to other ERAD mutants, but after 6 h, more than 12 % of the initial amount was left. This is on average more than double the amount than in the other strains, leaving only the Δyos9Δire1 strain with a higher IgG load. A notable difference in IgG depletion was observed for the Δubc7 strain, and 68 % of the IgG was left 2 h after addition of glucose, but the cellular IgG load became similar to other strains in this ERAD deletion strain at later time points. The Δubc7Δire1 strain also showed a slightly slower IgG depletion than the other strains in the Δire1 background. After 2 h, only 25 % of the initial IgG levels remained in the cell, but at later time points, the strain showed comparable signals to the other strains. In the Δire1 strain background, the IgG clearance was slowest in the Δhtm1Δire1 and the Δyos9Δire1 strains. In particular, the Δyos9Δire1 strain failed to deplete the total amount of IgG during the 6 h, whereas the Δhtm1Δire1 strain displayed a strongly delayed clearance, but IgG levels were depleted to similar levels as observed in the other strains after 6 h. After 2 h, still 42 and 51 %, respectively, of the initial amount of IgG were detected, which was approximately twice the amount when compared to the other strains. For the Δhtm1Δire1 strain, the decrease was slightly higher, with 14 and 6 % of the initial IgG concentration left after 4 and 6 h, respectively, whereas in the Δyos9Δire1 strain, 30 and 21 %, respectively, of the initial IgG concentration were left.
Discussion
Many studies have been performed to understand the underlying molecular mechanisms of the protein quality control systems in S. cerevisiae. Mechanistic insight of the functioning of components of the cellular protein QC system has been mainly gained from studies using model substrates which are prone to misfolding. Examples of these model ERAD substrates include CPY*, a truncated version of the vacuolar hydrolase carboxypeptidase Y, and PrA*, a mutated version of the glycoprotein proteinase A. These substrates have been used to gain information on the roles of, among others, Yos9p (Szathmary et al. 2005; Benitez et al. 2011 ), Htm1p (Clerc et al. 2009 ), and Ubc7p (Hiller et al. 1996) . From a biotechnologists' perspective, it is paramount to study these processes under more natural conditions and using real protein substrates. Unfortunately, so far, very few articles report on the influence of ERAD in combination with heterologous protein production. Fig. 6 Quantitative analysis of IgG clearance. Cultures of a strains in the wild-type (WT) background and b strains containing an IRE1 deletion were treated with glucose or water (control), and cellular IgG concentration was monitored over a period of 6 h. Total protein was separated on SDS-PAGE and transferred onto membranes. Blots were stained with an anti-IgG and an anti-tubulin antibody, respectively. Image Lab software was used for quantification of IgG and tubulin signal levels. Data represent the average of two blots normalized for loading differences using an anti-tubulin blot Producing heterologous proteins at high levels is prone to activate UPR and ERAD through crowding of the ER. For example, a study by Pfeffer et al. (2012) found that expression of the antibody fragment Fab3H6 in Pichia pastoris increased proteasomal activities by 20 % decreasing the product yield significantly. This indicates that ER quality control systems can also overshoot their requirements when expressing recombinant proteins, by targeting more than misfolded proteins for degradation. Manipulation of UPR has been used as well to improve heterologous protein production. Disruption and overexpression of HAC1 have been shown to lead to a decrease and increase, respectively, in the production of α-amylase in S. cerevisiae (Valkonen et al. 2003) . However, activation of the UPR as a whole has a great impact on various cellular processes and therefore does not improve our understanding of the contribution of individual components of UPR regulated genes in resolving the ER stress. Here, we studied the influence of selected proteins of the cellular QC system on the expression of a human IgG as a model protein and analyzed productivity, and intracellular accumulation of IgG and IgG clearance.
The data presented here shows that all strains used bearing a single deletion of an ERAD component, a deletion of IRE1 leading to an inactivated UPR, or a combination of both are viable and do not exhibit a growth phenotype under normal growth conditions. Similar results under normal conditions have been previously reported for the strains Δubc7, Δire1, and Δhrd1 (Friedlander et al. 2000; Apodaca et al. 2006; Li et al. 2012) and for the disruption of putative ERAD components in the filamentous fungi Aspergillus niger ). We observed a negative effect on growth only for Δhtm1Δire1 and Δyos9Δire1 strains when grown at 30 and 37°C and combining the elevated temperature with protein overexpression stress. However, growth of these strains was not affected under the normal conditions used for growth and expression of IgG in our experiments.
Deletion of single components of the ERAD system in the wild-type strain background allowed distinguishing between three distinct effects. A small increase in production was observed upon deletion of the HTM1 gene, a small decrease in IgG production of strains lacking the HRD1, HRD3, and UBC7 gene, and a more strong decrease was associated with the deletion of the YOS9 gene. In addition, IgG secretion was increased in the Δalg3 strains, a genotype which is considered not to produce the glycan signal for ERAD. It has been shown that removal of a mannose by Htm1p is required for efficient binding of ERAD targeted proteins to Yos9p (Szathmary et al. 2005; Clerc et al. 2009 ). Therefore, this could imply that the slowly folding IgG protein escapes from degradation through ERAD in the Δhtm1 background, giving it more time to fold and be secreted. In contrast, in all strains where the IgG is already marked for degradation, a reduced secretion was observed. In order to exclude any possibility for a rescue of IgG accumulation in the ER by the induction of UPR, we combined the single deletions with the IRE1 deletion. Such strains should be incapable to resolve ER stress by increased expression of folding chaperones. Interestingly, deletion of IRE1 had a strong effect on productivity in wild-type and partially reversed effects in Δhtm1 and Δyos9 background.
According to the current model, a glycoprotein in the ER of yeast can either reach its native state quickly and continue to the Golgi apparatus, remain in a folding intermediate state, or be degraded by the ERAD. It has also been proposed that slowly folding proteins can be removed from the ER. Therefore, we wanted to study whether the differences in productivity are connected to differences in the protein folding.
The strains most different from the wild-type and other strains tested in the clearance assay were the Δhrd1 and the Δubc7 strains and in the Δire1 genetic background the Δhtm1Δire1 and Δyos9Δire1 strains. In these strains, we observed a delayed clearance of IgG from the cells. Hrd1p and Ubc7p are part of the HRD-ligase complex. Changes in the IgG load over time can be attributed to two effects, either reaching the native folding state and leaving the ER to be secreted into the media, or degradation of the protein by the ERAD system. Based on the assumptions that once the IgG is properly folded, no differences, which would affect the secretion of the IgG, exist between different strains, and it is fair to assume that all the observed changes are due to changes in the rate of protein degradation. However, it cannot explain the observed differences in the IgG load after 6 h, unless after a prolonged incubation, similar levels as for other strains would be reached. An explanation could be that as the IgG fraction of the total amount of protein in the ER decreases, the relative IgG depletion also decreases. This will then be reflected in the decrease of clearance speed over time that is seen in the clearance assay. It has been shown that deletion of UBC7 leads to a decreased degradation of ERAD substrates (Hiller et al. 1996; Friedlander et al. 2000) . Also, for the HRD1 deletion, a delayed degradation of ERAD substrates has been found (Benitez et al. 2011) . In addition, misfolded substrates have shown to have an increased ER retention when HRD1 is deleted (Izawa et al. 2012) , which might contribute to the increased IgG load at the end of the clearance assay. Htm1p and Yos9p are responsible for generating and recognizing the glycan degradation signal in ERAD, respectively. Deleting these two proteins will abrogate formation of the recognition signal for targeting toward the translocation and ligase complex, leading to a longer residence time of the protein in the cells. The effect of Δhtm1Δire1 deletion on IgG clearance is less severe than in Δyos9Δire1, as Yos9p is known to also slowly recognize unfolded proteins based on hydrophobic patches and target them to the HRD complex (Benitez et al. 2011) . Supporting this, in the Δhtm1Δire1 strain, a decreased amount of secreted IgG compared with Δhtm1 was found. However, removal of Yos9p from ERAD removes the targeting step for retrotranslocation, which increases their residence time in the ER. This is also reflected by an increase in the specific production titers compared to the Δyos9 deletion strain. A reduced clearance had already been reported for CPY* and other artificial ERAD substrates (Szathmary et al. 2005; Clerc et al. 2009 ). In addition, a study in A. niger found indications for a delay in protein degradation when parts of the ERAD pathway were impaired, as high expression levels of heterologous proteins led to higher intracellular protein levels in these strains ). This also supports our finding that strains with a defect in ERAD had higher intracellular IgG level than the wild-type strain. However, almost all strains in the Δire1 background had lower intracellular IgG levels, indicating that in the wild-type strain background, the active UPR response pathway might obscure some of the observed effects.
In our study, we included also a Δalg3 strain, which produced slightly more IgG compared with wild-type yeast cells. Principally, this strain does not produce the typical Man 7 GlcNAc 2 glycan which is considered to be the canonical Yos9p recognition signal, having an exposed terminal α1,6-mannose at the C-branch. However, contrasting data has been published. It has been shown that the ALG3 mutation led to an increased accumulation of CPY* in the ER (Jakob et al. 1998 ). In contrast, other reports indicate that the glycan structure produced in the Δalg3 background, bearing as well a terminal α1, 6-mannose, is also recognized by Yos9p. In our study, we observe a similar IgG clearance in Δalg3 and wild-type strains, indicating that a substantial amount of IgG carrying the Man 5 GlcNAc 2 structure is cleared from the ER. Evidence for this hypothesis comes from a report of Clerc et al. (2009) who showed that in the Δalg3 strain, degradation of CPY* is similar in a Δyos9 deletion and Δalg3Δyos9 deletion strain.
In conclusion, deletion of various parts of the ERAD system, with or without an abolished UPR shows an interplay between these two quality control systems on production of antibodies and on cellular clearance of the produced antibody. However, the exact mechanism that causes these phenotypes in the different strains has yet to be elucidated.
